Bio-Techne
在场
是其中之一......
Bio-Techne 是一家在股票代码 TECH (US) 下上市的公司。
他们在：
涉及Bio-Techne的并购和融资。
- Bio-Techne has announced the acquisition of Lunaphore (公布2023六月23号).
高管
查看带有其 36 名主要高管的组织结构图
Bio-Techne 搜索最多的简介
- Kim Kelderman, Director, President and Chief Executive Officer
- Alpna Seth, Director
- Rupert Vessey, Director
高管在Bio-Techne变化
- Judith Klimovsky已作为Director加入公司 (新闻发布的2024五月2号).
创建提醒
跟踪 Bio-Techne 的高管变动
药店
Bio-Techne 拥有 1,835 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Bio-Techne 的最新新闻稿
- ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics :: Bio-Techne Corporation (TECH)
- Press Releases :: Bio-Techne Corporation (TECH)
- BIO-TECHNE DECLARES DIVIDEND :: Bio-Techne Corporation (TECH)
- BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS :: Bio-Techne Corporation (TECH)
- ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics :: Bio-Techne Corporation (TECH)
- ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences :: Bio-Techne Corporation (TECH)
- BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS :: Bio-Techne Corporation (TECH)
- ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences :: Bio-Techne Corporation (TECH)
- BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS :: Bio-Techne Corporation (TECH)
- ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff :: Bio-Techne Corporation (TECH)
- View more press releases Close
关于 Bio-Techne 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Kim Kelderman 
